FactMR today released its latest report on the Proteomics Market, providing comprehensive insights into the global market’s rapid growth driven by advancements in precision medicine, increasing demand for personalized therapies, and the rising prevalence of chronic diseases. Valued at USD 41.9 million in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 16.6%, reaching USD 194.6 million by 2034. This remarkable expansion underscores the critical role of proteomics in drug discovery, clinical diagnostics, and cancer research, transforming healthcare and biotechnology.
Market Outlook and Growth Projections
The proteomics market is poised for explosive growth from 2024 to 2034, fueled by the increasing application of proteomics in understanding protein functions, interactions, and modifications critical to disease mechanisms and therapeutic development. Proteomics, encompassing instruments, reagents, kits, and core services, supports the identification of biomarkers and drug targets, particularly for complex diseases like cancer and neurodegenerative disorders. The report projects the market to grow from USD 41.9 million in 2024 to USD 194.6 million by 2034, with a CAGR of 16.6%. This growth is driven by technological advancements in mass spectrometry, bioinformatics, and the global push for personalized medicine.
FactMR delivers comprehensive market reports and valuable business insights, uncovering trends, growth paths, and competitive landscapes. Committed to accuracy and reliability, FactMR empowers businesses with critical data and strategic recommendations, enhancing market positioning. With a global presence and experienced analysts, FactMR ensures reliable market intelligence, equipping clients to capitalize on opportunities.
For more information, visit https://www.factmr.com/report/proteomics-market
Comments
0 comment